Feruloylated Oligosaccharides Alleviate Central Nervous Inflammation in Mice Following Spinal Cord Contusion
mediaposted on 10.11.2020, 19:40 by Jing Li, Lu Huang, Ling-tai Yu, Gabriel Tao, Zi-ying Wang, Wen-zhi Hao, Jun-qing Huang
As one of the empirical models of the chronic central inflammatory response, a spinal cord injury (SCI) deteriorates the neuronal survival and results in irreversible motor and sensory dysfunction below the injury area. Our previous studies have reported that maize bran feruloylated oligosaccharides (FOs) exert significant anti-inflammatory activities both in diabetes and colitis. However, no direct evidence of FOs alleviating central nervous inflammation was stated. This study aimed to investigate the therapeutic effect of FOs on SCI and its potential mechanism. Our results indicated that 4 weeks of FO administration effectively mitigated the inflammatory response via decreasing the number of microglia (labelled with Iba1), result in the expression of IL-1α, IL-2, IL-6, IL-18 and TNF-α downregulating, but the level of IL-10 and BDNF increases in the injured spinal cord. Moreover, FOs enhanced neuronal survival, ameliorated the scar cavities, and improved behaviors, including Basso mouse scale (BMS) scores and the gait of mice after SCI. Together, these results demonstrated that administration of FOs showed superior functional recovery effects in a SCI model. Also, FOs may modulate inflammatory activities by regulating the expression of proinflammatory factors, decreasing the production of inflammatory cells, and promoting functional recovery through the MAPK pathway following SCI.
Read the peer-reviewed publication
BDNF increasesSCI modelTNF -α downregulatingproinflammatory factorsmaize bran feruloylated oligosaccha...MAPK pathway4 weeksBMSFO administrationFeruloylated Oligosaccharides Allev...cord injuryIL -10Spinal Cord Contusionrecovery effectsscar cavitiesBasso mouse scaleanti-inflammatory activitiesinjury area